每次来到位于吉林省磐石市的红石砬子抗日根据地遗址，马铖明都有新发现。作为杨靖宇将军的曾 孙，这名95后青年要用自己的眼睛，替曾祖父看看这片东北抗联战士们誓死守护的白山黑水，如今有了 哪些翻天覆地的变化。 去年，磐石市抗日斗争纪念馆、磐石市抗日民族统一战线历史纪念馆、李红光纪念馆、莲花山东北 抗联红色文化展览馆4个红色主题展馆，重新升级整合，让游客更立体、更多角度地了解东北抗联历 史。 近年来，"红色+旅游"让革命老区磐石热闹起来。相关数据显示，2024年，磐石市接待游客170万人 次，旅游总收入8.5亿元，其中红色旅游人数占比70%以上。 从磐石市区出发，一路向西行约20公里，就来到了红石砬子山。这里山高林密、地势险要、易守难 攻。中国共产党在这里建立了东北地区第一块抗日游击根据地——红石砬子抗日根据地，这里也是东北 抗日联军诞生和成长的摇篮。在红石砬子抗日根据地战斗过的国家级抗日英烈有杨靖宇、李红光等18位 之多。 "九一八"事变后，中共磐石中心县委机关、南满游击队总部及后勤保障部门都设在红石砬子山区。 杨靖宇带领南满游击队在此取得4次反"围剿"胜利，并积极探索和践行抗日民族统一战线，发展壮大队 伍。 在红 ...

Core Viewpoint - The article highlights the successful harvesting of purple ganoderma (lingzhi) in a 340-year-old lychee forest in Huizhou, showcasing the potential of under-forest economy and the benefits it brings to local communities [1][2]. Group 1: Economic Development - The ancient lychee forest in Tai Mei Town has been utilized to cultivate over 3,500 purple ganoderma, employing a fully simulated wild ecological planting technique, resulting in high-quality and nutritious products [1]. - In 2024, the village successfully harvested two batches of ganoderma, generating an income of 200,000 yuan for the village collective [1]. Group 2: Community Engagement - Local citizens participated in the harvesting event, expressing excitement and enjoyment, which indicates a strong community interest in the under-forest economy [1][2]. - The town's party secretary announced plans to develop the ancient lychee forest into an ecological demonstration base that integrates tourism, education, and harvesting, aiming to enhance public engagement and awareness of the under-forest economy [2].

Group 1 - Jilin Aodong (000623) participated in an investor relations event to enhance communication between investors and the company, showcasing its business scope which includes traditional Chinese medicine, chemical drugs, and health products [1] - The company has 628 production approval numbers, with 315 for traditional Chinese medicine, and aims to leverage its brand and product quality to enhance market value and sales of key products [1] - Jilin Aodong plans to cultivate multiple core products with over 100 million yuan in sales and accelerate the development of strategic products with a market potential of 10 billion yuan [1] Group 2 - The Yanbian Pharmaceutical project has completed several production facilities, which passed GMP compliance checks and are now contributing to revenue [2] - In 2024, the health business is expected to generate 212 million yuan in sales, accounting for 8.13% of total revenue, with over 200 health products produced and sold [2] - The company has 22 registered health food certificates and 85 filing certificates, with 43 products generating over 1 million yuan in sales [2] Group 3 - Jilin Aodong is enhancing brand awareness through diverse marketing strategies, including e-commerce and social media platforms like Douyin [3] - The company is focusing on the core value of traditional Chinese medicinal materials and aims to develop high-value projects through research and innovation [3] - The health product development system is driven by consumer health trends, emphasizing research and development of functional health products [3] Group 4 - The company is investing in core quality long-term equity securities and related pharmaceutical companies, collaborating with various funds to invest in biopharmaceuticals and internet healthcare [4] - Jilin Aodong aims to strengthen its research capabilities through indirect investments in distinctive and competitive biopharmaceutical projects [4] - The company is optimizing its financial asset allocation to create a positive cycle of financial capital supporting real industry growth [4]

编号：2025-005 | | √特定对象调研□分析师会议 | | --- | --- | | 投资者关系活 动类别 | □媒体采访□业绩说明会 | | | □新闻发布会□路演活动 | | | √现场参观 | | | □其他（请文字说明其他活动内容） | | | 现场参观调研 | | 参与单位名称 | 国泰海通证券投资者教育基地、全景投资者教育上海基地、工 | | 及人员姓名 | 商银行、奇迹基金、中创投资、亚东投资、琢磨基金、探普资 | | | 产、上海磬晟投资及个人投资者 | | 时间 | 2025 年 7 月 4 日 | | 地点 | 吉林省敦化市敖东大街 2158 号 | | 上市公司接待 | 副董事长、总经理：郭淑芹 | | | 董事、副总经理：杨凯 | | | 董事、副总经理、财务总监：张淑媛 | | 人员姓名 | 董事、副总经理、董事会秘书：王振宇 | | | 董事、党委书记：赵大龙 | | | 副总经理：林晓林 | | | 由国泰海通证券、全景网主办的"吉聚资本 鹿鸣东方—走 | | | 进上市公司"主题活动走进吉林敖东，通过与企业家面对面交 | | | 流、实地走访的形式，让投资者更加深入全 ...

寿仙谷（603896）公告，近日，公司全资子公司金华寿仙谷药业有限公司的"寿仙云 破壁灵芝孢子粉 片"及"寿仙红 破壁灵芝孢子粉片"两款产品完成了国产保健食品备案工作，并获得浙江省市场监督管理 局发放的国产保健食品备案凭证。上述产品备案成功不会对公司近期的生产经营产生重大影响，但有利 于进一步补充完善公司的产品品类，丰富公司的产品线，提升公司在保健食品领域的竞争力，符合公司 布局大健康产业的战略规划。 ...

不是所有的灵芝种子都能被送上太空，但寿仙谷做到了。 四十多年的科研生涯里，李明焱从南下种银耳的青年，成长为中国灵芝产业的"破壁者"。在浙江武义的 塑料大棚和田埂间，他成功改良驯化了野生灵芝与石斛，也造就了中国灵芝与铁皮石斛行业的上市第一 股——寿仙谷。 如今，这位65岁的"科研型企业家"仍未停下脚步。在中医药振兴与大健康产业升级的新时代浪潮中，他 依然奔走在科研前线与产业一线。李明焱认为，中医药的未来不是传承与现代化的二选一，而是科技、 标准与数字化的融合共生。未来，寿仙谷将不断加强科技创新，用技术持续赋能产业创新。 "没有标准，谈何交流？" "品种不攻破，就没法推进产业变革。"这是寿仙谷董事长李明焱坚信的朴素道理。 1909年，李明焱的祖父在武义开了一家名叫"寿仙谷"的中药铺。从小闻着中药香长大的李明焱并未直接 走上前辈的路子——22岁时，他颇为"叛逆"地只身前往福建学习银耳栽培，回乡后投身菌类种植，成为 当地第一位"青年星火带头人"，也就有了后来公派日本留学的故事。 研学期间，海外工厂给了年轻的李明焱极大震撼："原来采药加工也可以做到标准化、规模化，全流程 都用现代装备进行。"彼时，国内中药材种植尚未形成 ...

证券研究报告：医药生物 | 公司点评报告 发布时间：2025-07-02 股票投资评级 资料来源：聚源，中邮证券研究所 公司基本情况 业绩承压，新产品新渠道探索打开成长空间 l 受消费环境影响，业绩承压 2024 年营业收入 6.92 亿元（-11.81%），归母净利润 1.75 亿元 （-31.34%），扣非净利润1.43 亿元（-36.96%），经营现金流净额 2.13 亿元（-32.25%）。2025Q1 营业收入 1.71 亿元（-22.68%），归母净利 润 0.58 亿元（-24.32%），扣非净利润 0.39 亿元（-42.91%）。收费疲 软导致公司业绩承压。 l 探索新渠道，推行经销商改制，拥抱新零售 公司持续巩固和完善"名医、名药、名店"销售模式，稳市场、稳 销售、挖潜力。省外市场实行经销改制模式，广东、安徽、湖北等完 成经销商改制。推进"百城千店"计划，探索连锁药店+专卖店模式，累 计开设 16 家连锁药店；大药房"批零一体"新商业经营模式正式上线。 同时，以数字化赋能营销改革，DIMS 第一期内容上线，寿仙谷营销 数智化进程进入试运行。 l 新产品丰富产品矩阵，落实大健康产业战略 20 ...

Core Viewpoint - The development of the forest-based Chinese medicinal herb industry in China has shown significant progress, with various regions implementing measures to promote high-quality growth through the utilization of forest ecological environments and the cultivation of medicinal herbs under forest canopies [1][2]. Group 1: Industry Development - The industry has seen the establishment of geographical indication products such as Ganoderma lucidum and Camellia flower tea in Guangxi, and the promotion of the "Xiang Nine Flavors" under-forest cultivation system in Hunan [1]. - There is a shift from traditional cultivation to initial processing and deep processing of medicinal herbs, leading to a diverse product system including Chinese medicinal slices, extracts, proprietary Chinese medicines, health foods, and cosmetics [1][2]. Group 2: Advantages of Under-Forest Cultivation - Under-forest cultivation allows for wild-simulated planting, reducing human intervention and enhancing the quality of medicinal herbs [1]. - The method enables the use of different types of medicinal herbs in various forest types, maximizing resource utilization through multi-layered planting [1]. - Breakthroughs in selecting shade-tolerant and shade-loving varieties have addressed challenges related to canopy density, ensuring higher yields and quality [1]. Group 3: Challenges in the Industry - There are significant issues regarding environmental adaptability, as different medicinal herbs have varying light requirements that must be matched with forest canopy density for optimal growth [2]. - The industry faces bottlenecks in germplasm and cultivation technology, with problems such as mixed and degraded seed sources and a lack of standardized seedlings [2]. - Harvesting and processing technologies are limited due to the complex terrain of under-forest areas, restricting the use of traditional harvesting machinery and the availability of initial processing facilities [2]. Group 4: Strategies for High-Quality Development - Technological empowerment is essential for driving high-quality development in the under-forest medicinal herb industry, transitioning from reliance on natural conditions to data-driven approaches [2]. - Brand building is crucial for enhancing product value and market competitiveness, addressing the issue of "high quality but low price" [2]. - The integration of primary, secondary, and tertiary industries is vital for transforming the industry from a simple "planting and selling" model to a modern integrated system encompassing cultivation, processing, and services [2][3]. Group 5: Ecological and Economic Balance - Achieving a balance between ecological protection and economic benefits requires tailored planning based on forest resource distribution, appropriate variety selection, and rational planting density [3]. - Focusing on specialty industries and exploring the ecological potential of forest land can enhance the value of local medicinal herbs and promote deep processing [3]. - Strengthening regulatory frameworks and implementing standardized production practices are necessary to ensure product quality and safeguard the healthy development of the industry [3].

一纸超千万的罚单再度将浙江维康药业股份有限公司（简称"维康药业"）置于风口浪尖。近日，维康药 业发布公告称，因涉嫌信息披露违法违规，公司及实际控制人刘忠良被立案调查。调查结果显示，维康 药业未按规定披露关联方非经营性资金占用，且可转债募集说明书存在不准确、不完整的情况。依据相 关规定，浙江证监局拟决定对维康药业及公司多名责任人给予警告并处罚款，罚款金额总计1460万元。 实控人长期占用公司资金 2024年12月底，维康药业及其实控人刘忠良收到中国证监会下发的立案告知书，因涉嫌信息披露违法违 规，中国证监会决定对公司及公司实际控制人刘忠良立案。 最新的浙江证监局的《行政处罚事先告知书》显示，案涉期间，维康药业时任董事长、实际控制人刘忠 良组织、指使维康药业以支付工程设备款名义转出部分资金，经工程设备商后，资金最终转至刘忠良控 制的个人账户，上述行为构成关联方非经营性资金占用。 从数据来看，2020年、2021年、2022年、2023年1-6月资金占用期末余额分别为7811.88万元、8950.65万 元、1.47亿元、1.51亿元，分别占当期净资产的5.64%、6.35%、10.43%、10.24%。截至202 ...

记者 李山 浙江证监局一纸千万罚单，揭开了维康药业（300878）长达四年的资金占用黑幕。2025年6月27日，维 康药业公告收到《行政处罚事先告知书》，因未披露关联方资金占用及可转债募集说明书存在虚假记 载，公司及实控人刘忠良被处以总计超过1400万元罚款。 调查显示，2020年至2023年6月期间，刘忠良通过工程设备款名义转移上市公司资金至个人账户，累计 占用资金超过1.5亿元，最高年份占比净资产超10%，却从未在定期报告中披露。更严重的是，公司在 2022年申请发行可转债时，仍声称"不存在资金被实际控制人占用"，直接导致申报文件失实。 四年隐秘占资，穿透合规"防火墙" 资金占用手法直指实际控制人操控软肋。浙江证监局调查认定，刘忠良组织公司以支付工程设备款名义 转出资金，经中间账户周转后，最终流入其个人控制账户。 四年间占资规模持续攀升：从2020年的7811万元增至2023年中的1.51亿元，分别占当期净资产的 5.64%、6.35%、10.43%、10.24%。 这些交易既未履行审议程序，也未在2020-2022年报及2023年半年报中披露。直至2024年4月浙江证监局 现场检查才首次暴露问题。 监管 ...